Exicure Inc
Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie Inc. to develop SNA-based treatments for hair loss disorders; and collaboration agreement with Ipsen S.A. to research, develop, and commercialize novel spherical nucleic acids for Huntington's disease and Angelman syndrome. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois. Show More...
-
Website https://www.exicuretx.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 9.87 USD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD -0.43 -0.28 -0.54 -0.46 -0.33 Dividends USD Payout Ratio % * Shares Mil 39.0 39.0 41.0 58.0 69.0 Book Value Per Share * USD 0.57 0.75 0.98 Free Cash Flow Per Share * USD -0.43 -0.41 Return on Assets % -82.33 -49.51 -78.9 -36.53 -30.4 Financial Leverage (Average) 1.48 1.37 1.43 1.24 Return on Equity % -112.35 -51.73 -39.24 Return on Invested Capital % -87.53 -43.85 -36.8 Interest Coverage -22.4 -14.14 -32.35 -32.46 -26.18 Current Ratio 1.65 7.74 13.54 3.63 4.99 Quick Ratio 1.62 7.47 12.86 3.57 4.87 Debt/Equity 0.26 0.24